SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-014197
Filing Date
2024-02-15
Accepted
2024-02-14 17:35:36
Documents
23
Period of Report
2024-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193687-8k_phoenix.htm   iXBRL 8-K 209174
2 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CERO THERAPEUTICS HO ea193687ex3-1_phoenix.htm EX-3.1 35476
3 SECOND AMENDED AND RESTATED BYLAWS OF CERO THERAPEUTICS HOLDINGS, INC ea193687ex3-2_phoenix.htm EX-3.2 187286
4 INVESTOR RIGHTS AND LOCK-UP AGREEMENT, DATED FEBRUARY 14, 2024, BY AND BETWEEN P ea193687ex10-7_phoenix.htm EX-10.7 208455
5 REGISTRATION RIGHTS AGREEMENT, DATED AS OF FEBRUARY 14, 2024, BY AND BETWEEN PHO ea193687ex10-9_phoenix.htm EX-10.9 178232
6 REGISTRATION RIGHTS AGREEMENT, DATED AS OF FEBRUARY 14, 2024, BY AND BETWEEN CER ea193687ex10-11_phoenix.htm EX-10.11 146862
7 FORM OF SHARE REALLOCATION AGREEMENT, DATED AS OF FEBRUARY 14, 2024, BY AND AMON ea193687ex10-12_phoenix.htm EX-10.12 72382
8 LIST OF SUBSIDIARIES OF CERO THERAPEUTICS HOLDINGS, INC ea193687ex21-1_phoenix.htm EX-21.1 2239
9 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF CERO THERAPEUTIC ea193687ex99-1_phoenix.htm EX-99.1 196022
  Complete submission text file 0001213900-24-014197.txt   1714331

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE pbax-20240213.xsd EX-101.SCH 3893
11 XBRL DEFINITION FILE pbax-20240213_def.xml EX-101.DEF 28829
12 XBRL LABEL FILE pbax-20240213_lab.xml EX-101.LAB 38680
13 XBRL PRESENTATION FILE pbax-20240213_pre.xml EX-101.PRE 27038
25 EXTRACTED XBRL INSTANCE DOCUMENT ea193687-8k_phoenix_htm.xml XML 7692
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 24640860
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)